AWM
BIO icon

Accurate Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Accurate Wealth Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7
Closed -$3.03K – 371
2022
Q4 		$3.03K Buy
+7
New +$2.83K ﹤0.01% 1115

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Accurate Wealth Management's BIO Position: Q1 2023 in Review

Accurate Wealth Management sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2023, closing a stake of 7 shares — an estimated $3.03K sold.

Accurate Wealth Management first reported a position in BIO in Q4 2022 and held it in 1 quarter. The position peaked at $3.03K in Q4 2022. 505 funds tracked by Wall St. Rank hold BIO as of Q1 2023.

  • Accurate Wealth Management reported no remaining Bio-Rad Laboratories Class A position as of Q1 2023 after selling out during the quarter.
  • Accurate Wealth Management sold 7 Bio-Rad Laboratories Class A shares in Q1 2023, an estimated $3.03K.
  • Accurate Wealth Management first reported a position in Bio-Rad Laboratories Class A in Q4 2022 and held it in 1 quarter.
  • Accurate Wealth Management's Bio-Rad Laboratories Class A position peaked at $3.03K in Q4 2022.
  • 505 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2023.

Based on Accurate Wealth Management's 13F filing for Q1 2023, filed 13 Apr 2023.